2005年5月第10期
·07/05/08 WHO-EORTC classification for cutaneous lymphomas
·07/05/08 Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1
·07/05/08 Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)–dependent window during hematopoietic stem-cell development
·07/05/08 NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
·07/05/08 Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656
·07/05/08 The actin cytoskeleton differentially regulates platelet -granule and dense-granule secretion
·07/05/08 Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation
·07/05/08 Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase /PRSS22
·07/05/08 Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants
·07/05/08 Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B
·07/05/08 New trends in umbilical cord blood transplantation
·07/05/08 Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein–specific morphology and migration of endothelial cells
·07/05/08 Rapid ubiquitination of Syk following GPVI activation in platelets
·07/05/08 Deficiency in the p110 subunit of PI3K results in diminished Tie2 expression and Tie2-/-–like vascular defects in mice
·07/05/08 Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor
·07/05/08 Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
·07/05/08 Membrane type 1–matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium
·07/05/08 Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells
·07/05/08 An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma
·07/05/08 Expression of the human germinal center–associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
·07/05/08 Activation of Src kinase Lyn by the Kaposi sarcoma–associated herpesvirus K1 protein: implications for lymphomagenesis
·07/05/08 Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells
·07/05/08 PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
·07/05/08 Vitamin C protects HL60 and U266 cells from arsenic toxicity
·07/05/08 Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
·07/05/08 Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance
·07/05/08 The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production
·07/05/08 Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD
·07/05/08 Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
·07/05/08 Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
·07/05/08 Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients
·07/05/08 Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance
·07/05/08 Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
·07/05/08 Trafficking of the major virulence factor to the surface of transfected P falciparum–infected erythrocytes
·07/05/08 Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia
·07/05/08 Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1
·07/05/08 Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)–dependent window during hematopoietic stem-cell development
·07/05/08 NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
·07/05/08 Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656
·07/05/08 The actin cytoskeleton differentially regulates platelet -granule and dense-granule secretion
·07/05/08 Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation
·07/05/08 Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase /PRSS22
·07/05/08 Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants
·07/05/08 Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B
·07/05/08 New trends in umbilical cord blood transplantation
·07/05/08 Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein–specific morphology and migration of endothelial cells
·07/05/08 Rapid ubiquitination of Syk following GPVI activation in platelets
·07/05/08 Deficiency in the p110 subunit of PI3K results in diminished Tie2 expression and Tie2-/-–like vascular defects in mice
·07/05/08 Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor
·07/05/08 Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
·07/05/08 Membrane type 1–matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium
·07/05/08 Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells
·07/05/08 An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma
·07/05/08 Expression of the human germinal center–associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
·07/05/08 Activation of Src kinase Lyn by the Kaposi sarcoma–associated herpesvirus K1 protein: implications for lymphomagenesis
·07/05/08 Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells
·07/05/08 PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
·07/05/08 Vitamin C protects HL60 and U266 cells from arsenic toxicity
·07/05/08 Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
·07/05/08 Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance
·07/05/08 The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production
·07/05/08 Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD
·07/05/08 Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
·07/05/08 Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
·07/05/08 Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients
·07/05/08 Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance
·07/05/08 Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
·07/05/08 Trafficking of the major virulence factor to the surface of transfected P falciparum–infected erythrocytes
·07/05/08 Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia
栏目列表
·2005年7月第13期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期